NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.4750
+0.0734 (18.28%)
Sep 4, 2026, 2:33 PM EDT - Market open
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $17.56 million as of September 4, 2026. Its market cap has decreased by -34.46% in one year.
Market Cap
17.56M
Enterprise Value
17.57M
1-Year Change
-34.46%
Ranking
Category
Stock Price
$0.48
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $17.56M, a decrease of -72.82%. That is a compound annual growth rate of -24.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 17.56M | -23.10% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioCardia | 16.80M |
| Psyence Biomedical | 16.67M |
| Adial Pharmaceuticals | 16.60M |
| Citius Pharmaceuticals | 15.91M |
| Pluri | 15.32M |
| BioVie | 15.31M |
| Vyome Holdings | 15.30M |
| Passage Bio | 14.96M |